A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders
Clinical trial NCT02985190 · COMPLETED
Trial details
- NCT number
- NCT02985190
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2021-09-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.